RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) on January 13 and set a price target of $40.00. The ...
19h
Better-than-expected Core CPI for December led to a sharp fall in US Treasury yields as stocks gained premarket, boosted by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback